Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 43

1.

Age-related decreases in relapses among adults with relapsing-onset multiple sclerosis.

Schwehr NA, Kuntz KM, Butler M, Enns EA, Shippee ND, Kingwell E, Tremlett H, Carpenter AF; BeAMS Study Group.

Mult Scler. 2019 Jul 29:1352458519866613. doi: 10.1177/1352458519866613. [Epub ahead of print]

PMID:
31354041
2.

A MiSeq-HyDRA platform for enhanced HIV drug resistance genotyping and surveillance.

Taylor T, Lee ER, Nykoluk M, Enns E, Liang B, Capina R, Gauthier MK, Domselaar GV, Sandstrom P, Brooks J, Ji H.

Sci Rep. 2019 Jun 20;9(1):8970. doi: 10.1038/s41598-019-45328-3.

3.

Proactive Vs Reactive Therapeutic Drug Monitoring of Infliximab in Crohn's Disease: A Cost-Effectiveness Analysis in a Simulated Cohort.

Negoescu DM, Enns EA, Swanhorst B, Baumgartner B, Campbell JP, Osterman MT, Papamichael K, Cheifetz AS, Vaughn BP.

Inflamm Bowel Dis. 2019 Jun 10. pii: izz113. doi: 10.1093/ibd/izz113. [Epub ahead of print]

PMID:
31184366
4.

"Time Traveling Is Just Too Dangerous" but Some Methods Are Worth Revisiting: The Advantages of Expected Loss Curves Over Cost-Effectiveness Acceptability Curves and Frontier.

Alarid-Escudero F, Enns EA, Kuntz KM, Michaud TL, Jalal H.

Value Health. 2019 May;22(5):611-618. doi: 10.1016/j.jval.2019.02.008.

PMID:
31104743
5.

Cost-effectiveness of treatment regimens for Clostridioides difficile infection -an evaluation of the 2018 Infectious Diseases Society of America guidelines.

Rajasingham R, Enns EA, Khoruts A, Vaughn BP.

Clin Infect Dis. 2019 Apr 17. pii: ciz318. doi: 10.1093/cid/ciz318. [Epub ahead of print]

PMID:
31001619
6.

HIV Care Trajectories as a Novel Longitudinal Assessment of Retention in Care.

Enns EA, Reilly CS, Horvath KJ, Baker-James K, Henry K.

AIDS Behav. 2019 Mar 9. doi: 10.1007/s10461-019-02450-7. [Epub ahead of print]

PMID:
30852729
7.

Bioinformatic data processing pipelines in support of next-generation sequencing-based HIV drug resistance testing: the Winnipeg Consensus.

Ji H, Enns E, Brumme CJ, Parkin N, Howison M, Lee ER, Capina R, Marinier E, Avila-Rios S, Sandstrom P, Van Domselaar G, Harrigan R, Paredes R, Kantor R, Noguera-Julian M.

J Int AIDS Soc. 2018 Oct;21(10):e25193. doi: 10.1002/jia2.25193.

8.

Modeling cost-effectiveness of risk-based bovine tuberculosis surveillance in Minnesota.

Kao SZ, VanderWaal K, Enns EA, Craft ME, Alvarez J, Picasso C, Wells SJ.

Prev Vet Med. 2018 Nov 1;159:1-11. doi: 10.1016/j.prevetmed.2018.08.011. Epub 2018 Aug 26.

PMID:
30314771
9.

Nonidentifiability in Model Calibration and Implications for Medical Decision Making.

Alarid-Escudero F, MacLehose RF, Peralta Y, Kuntz KM, Enns EA.

Med Decis Making. 2018 Oct;38(7):810-821. doi: 10.1177/0272989X18792283.

PMID:
30248276
10.

Revisiting assumptions about age-based mixing representations in mathematical models of sexually transmitted infections.

Easterly CW, Alarid-Escudero F, Enns EA, Kulasingam S.

Vaccine. 2018 Sep 5;36(37):5572-5579. doi: 10.1016/j.vaccine.2018.07.058. Epub 2018 Aug 6.

PMID:
30093290
11.

Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model - CORRIGENDUM.

Alarid-Escudero F, Enns EA, MacLehose RF, Parsonnet J, Torres J, Kuntz KM.

Epidemiol Infect. 2018 Jun;146(8):1070. doi: 10.1017/S0950268818001371. No abstract available.

PMID:
29893664
12.

Force of infection of Helicobacter pylori in Mexico: evidence from a national survey using a hierarchical Bayesian model.

Alarid-Escudero F, Enns EA, MacLehose RF, Parsonnet J, Torres J, Kuntz KM.

Epidemiol Infect. 2018 Jun;146(8):961-969. doi: 10.1017/S0950268818000857. Epub 2018 Apr 16. Erratum in: Epidemiol Infect. 2018 Jun;146(8):1070.

13.

Microsimulation Modeling for Health Decision Sciences Using R: A Tutorial.

Krijkamp EM, Alarid-Escudero F, Enns EA, Jalal HJ, Hunink MGM, Pechlivanoglou P.

Med Decis Making. 2018 Apr;38(3):400-422. doi: 10.1177/0272989X18754513.

14.

Cost-Effectiveness of Antibiotic Prophylaxis Strategies for Transrectal Prostate Biopsy in an Era of Increasing Antimicrobial Resistance.

Lee K, Drekonja DM, Enns EA.

Value Health. 2018 Mar;21(3):310-317. doi: 10.1016/j.jval.2017.08.3016. Epub 2017 Oct 18.

15.

Decision Science Can Help Policymakers to Identify and Evaluate Policies to Treat Opioid Use Disorder Among Pregnant Women.

Thao V, Enns EA, Patrick SW, Levy R, Kozhimannil KB.

Womens Health Issues. 2018 Jan - Feb;28(1):2-5. doi: 10.1016/j.whi.2017.10.008. No abstract available.

PMID:
29268879
16.

Using Multiple Outcomes of Sexual Behavior to Provide Insights Into Chlamydia Transmission and the Effectiveness of Prevention Interventions in Adolescents.

Enns EA, Kao SY, Kozhimannil KB, Kahn J, Farris J, Kulasingam SL.

Sex Transm Dis. 2017 Oct;44(10):619-626. doi: 10.1097/OLQ.0000000000000653.

17.

Optimal surveillance strategies for bovine tuberculosis in a low-prevalence country.

VanderWaal K, Enns EA, Picasso C, Alvarez J, Perez A, Fernandez F, Gil A, Craft M, Wells S.

Sci Rep. 2017 Jun 23;7(1):4140. doi: 10.1038/s41598-017-04466-2.

18.

An Overview of R in Health Decision Sciences.

Jalal H, Pechlivanoglou P, Krijkamp E, Alarid-Escudero F, Enns E, Hunink MGM.

Med Decis Making. 2017 Oct;37(7):735-746. doi: 10.1177/0272989X16686559. Epub 2017 Jan 6. Review.

PMID:
28061043
19.

Potential Impact of Integrating HIV Surveillance and Clinic Data on Retention-in-Care Estimates and Re-Engagement Efforts.

Enns EA, Reilly CS, Virnig BA, Baker K, Vogenthaler N, Henry K.

AIDS Patient Care STDS. 2016 Sep;30(9):409-15. doi: 10.1089/apc.2016.0169.

20.

Evaluating empirical contact networks as potential transmission pathways for infectious diseases.

VanderWaal K, Enns EA, Picasso C, Packer C, Craft ME.

J R Soc Interface. 2016 Aug;13(121). pii: 20160166. doi: 10.1098/rsif.2016.0166.

21.

Prevalence of Inappropriate Antibiotic Prescriptions Among US Ambulatory Care Visits, 2010-2011.

Fleming-Dutra KE, Hersh AL, Shapiro DJ, Bartoces M, Enns EA, File TM Jr, Finkelstein JA, Gerber JS, Hyun DY, Linder JA, Lynfield R, Margolis DJ, May LS, Merenstein D, Metlay JP, Newland JG, Piccirillo JF, Roberts RM, Sanchez GV, Suda KJ, Thomas A, Woo TM, Zetts RM, Hicks LA.

JAMA. 2016 May 3;315(17):1864-73. doi: 10.1001/jama.2016.4151.

PMID:
27139059
22.

Network analysis of cattle movements in Uruguay: Quantifying heterogeneity for risk-based disease surveillance and control.

VanderWaal KL, Picasso C, Enns EA, Craft ME, Alvarez J, Fernandez F, Gil A, Perez A, Wells S.

Prev Vet Med. 2016 Jan 1;123:12-22. doi: 10.1016/j.prevetmed.2015.12.003. Epub 2015 Dec 10.

PMID:
26708252
23.

Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada.

Enns EA, Zaric GS, Strike CJ, Jairam JA, Kolla G, Bayoumi AM.

Addiction. 2016 Mar;111(3):475-89. doi: 10.1111/add.13195. Epub 2015 Nov 30.

PMID:
26616368
24.

Understanding Trends in Pertussis Incidence: An Agent-Based Model Approach.

Sanstead E, Kenyon C, Rowley S, Enns E, Miller C, Ehresmann K, Kulasingam S.

Am J Public Health. 2015 Sep;105(9):e42-7. doi: 10.2105/AJPH.2015.302794. Epub 2015 Jul 16.

25.

Estimating the Burden of Osteoarthritis to Plan for the Future.

Marshall DA, Vanderby S, Barnabe C, MacDonald KV, Maxwell C, Mosher D, Wasylak T, Lix L, Enns E, Frank C, Noseworthy T.

Arthritis Care Res (Hoboken). 2015 Oct;67(10):1379-86. doi: 10.1002/acr.22612.

26.

Link removal for the control of stochastically evolving epidemics over networks: a comparison of approaches.

Enns EA, Brandeau ML.

J Theor Biol. 2015 Apr 21;371:154-65. doi: 10.1016/j.jtbi.2015.02.005. Epub 2015 Feb 16.

27.

From network analysis to risk analysis--An approach to risk-based surveillance for bovine tuberculosis in Minnesota, US.

Ribeiro-Lima J, Enns EA, Thompson B, Craft ME, Wells SJ.

Prev Vet Med. 2015 Mar 1;118(4):328-40. doi: 10.1016/j.prevetmed.2014.12.007. Epub 2014 Dec 19.

PMID:
25577678
28.

Behavioral and community correlates of adolescent pregnancy and Chlamydia rates in rural counties in Minnesota.

Kozhimannil KB, Enns E, Blauer-Peterson C, Farris J, Kahn J, Kulasingam S.

J Community Health. 2015 Jun;40(3):493-500. doi: 10.1007/s10900-014-9962-3.

29.

Identifying best-fitting inputs in health-economic model calibration: a Pareto frontier approach.

Enns EA, Cipriano LE, Simons CT, Kong CY.

Med Decis Making. 2015 Feb;35(2):170-82. doi: 10.1177/0272989X14528382. Epub 2014 May 5.

30.

Cost-effectiveness of treatment of diabetic macular edema.

Pershing S, Enns EA, Matesic B, Owens DK, Goldhaber-Fiebert JD.

Ann Intern Med. 2014 Jan 7;160(1):18-29. doi: 10.7326/M13-0768.

31.

A controlled quality improvement trial to reduce the use of physical restraints in older hospitalized adults.

Enns E, Rhemtulla R, Ewa V, Fruetel K, Holroyd-Leduc JM.

J Am Geriatr Soc. 2014 Mar;62(3):541-5. doi: 10.1111/jgs.12710. Epub 2014 Feb 12.

PMID:
24517583
32.

Phenytoin-induced reduction in sirolimus levels.

Bates D, Burak KW, Coffin CS, Ying T, Enns EM.

Can J Hosp Pharm. 2011 Jul;64(4):271-4. No abstract available.

33.

Optimal link removal for epidemic mitigation: a two-way partitioning approach.

Enns EA, Mounzer JJ, Brandeau ML.

Math Biosci. 2012 Feb;235(2):138-47. doi: 10.1016/j.mbs.2011.11.006. Epub 2011 Nov 16.

34.

Assessing effectiveness and cost-effectiveness of concurrency reduction for HIV prevention.

Enns EA, Brandeau ML, Igeme TK, Bendavid E.

Int J STD AIDS. 2011 Oct;22(10):558-67. doi: 10.1258/ijsa.2011.010322.

35.

Inferring model parameters in network-based disease simulation.

Enns EA, Brandeau ML.

Health Care Manag Sci. 2011 Jun;14(2):174-88. doi: 10.1007/s10729-011-9150-2. Epub 2011 Mar 5.

36.

Population strategies to decrease sodium intake and the burden of cardiovascular disease: a cost-effectiveness analysis.

Smith-Spangler CM, Juusola JL, Enns EA, Owens DK, Garber AM.

Ann Intern Med. 2010 Apr 20;152(8):481-7, W170-3. doi: 10.7326/0003-4819-152-8-201004200-00212. Epub 2010 Mar 1.

PMID:
20194225
37.

Examining the relationship between genetic counselors' attitudes toward deaf people and the genetic counseling session.

Enns EE, Boudreault P, Palmer CG.

J Genet Couns. 2010 Apr;19(2):161-73. doi: 10.1007/s10897-009-9272-6. Epub 2009 Nov 11.

38.

Promotion of healthy weights at preschool public health vaccination clinics in Calgary: an obesity surveillance program.

Flynn MA, Hall K, Noack A, Clovechok S, Enns E, Pivnick J, Naimish A, Wouts P, Best M, Pryce C.

Can J Public Health. 2005 Nov-Dec;96(6):421-6.

PMID:
16350865
39.

A locking mechanism preventing radical damage in the absence of substrate, as revealed by the x-ray structure of lysine 5,6-aminomutase.

Berkovitch F, Behshad E, Tang KH, Enns EA, Frey PA, Drennan CL.

Proc Natl Acad Sci U S A. 2004 Nov 9;101(45):15870-5. Epub 2004 Oct 28.

40.

[Endoscopic method for the diagnosis and treatment of spinal pain syndromes].

Shutse G, Kurtse G, Grol O, Enns E.

Anesteziol Reanimatol. 1996 Jul-Aug;(4):62-4. Russian.

PMID:
8975576
41.

Relationship between regional ventilation and aerosol deposition in tidal breathing.

Trajan M, Logus JW, Enns EG, Man SF.

Am Rev Respir Dis. 1984 Jul;130(1):64-70.

PMID:
6377999
42.

Planar Brownian motion in the presence of an attractive force.

Enns EG, Fung TS, Rowlands S, Seachand LS.

Cell Biophys. 1983 Sep;5(3):189-95.

PMID:
6199112
43.

A quantum mechanical interaction of human erythrocytes.

Rowlands S, Sewchand LS, Enns EG.

Can J Physiol Pharmacol. 1982 Jan;60(1):52-9.

PMID:
7066754

Supplemental Content

Support Center